Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Rituximab can cause skin issues, but baricitinib may help improve them.

Topical tretinoin 0.01% cream effectively treats eruptive vellus hair cysts.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Managing recurrent painless thyroiditis is challenging and should be personalized based on episode frequency, severity, symptoms, and patient preferences.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Rifampicin effectively treated tufted hair folliculitis with no relapse after one year.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Retinoids help manage skin conditions in black individuals.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Ritlecitinib is safe and may effectively treat alopecia areata.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.